DENVER, Sept. 02, 2016 -- Global cannabidiol (CBD) manufacturer Elixinol is the first company in the world to receive the seal of approval for its CBD products from Realm of Caring, a global non-profit providing support services, resources and research for cannabinoid users.
|
|||
The Realm of Caring seal of approval, the first of its kind in the cannabis industry is awarded to companies after a lengthy independent review of manufacturing and sourcing practices. The seal of approval provides those using CBD with a way to identify the highest-quality CBD in the marketplace.
The circular seal will be included on all Elixinol products beginning October 1, 2016 and customers will see the Realm of Caring seal of approval online at Elixinol.com immediately.
“We’re honored to have our organic, whole-plant CBD be the first awarded this prestigious recognition of high quality CBD by Realm of Caring, an industry leader and educator,” said Paul Benhaim, Elixinol co-founder. “We know it’s important for those using CBD to be able to trust the product. To see our efforts, which are setting the global standard for the CBD industry, recognized is truly rewarding.”
Elixinol is also partnering with Realm of Caring clients on important CBD research at Johns Hopkins University, including those affected by numerous disorders and diseases including Cancer, Multiple Sclerosis, Chronic Pain, HIV/AIDS, Epilepsy, and Parkinson's to name a few.
“Education and research is an important core mission of Elixinol. The more people understand about CBD, the more they can make informed choices, and we want to help them get the best information and the highest-quality product, so this seal of approval is truly a reflection of our expectations of ourselves, our process and the future of CBD,” said Benhaim.
About Elixinol:
Colorado-based Elixinol, founded by Paul Benhaim, hemp entrepreneur since 1991, is widely regarded as one of the most influential CBD manufacturers in the world. With a proven track record of growing and manufacturing high-quality hemp, Elixinol also conducts rigorous laboratory testing and quality control. A global leader in distribution, consulting and hemp education, Elixinol distributes CBD products in the United States, Japan, Puerto Rico and the UK. Elixinol and its global partners, including Elixinol Japan, recently introduced hemp oil Liposomes, with superior absorption and real fruit flavor, and the X-pen, the most precise CBD oil delivery system. More information available at Elixinol.com.
About The Realm of Caring Foundation:
The Realm of Caring is a 501(c)3 non-profit that provides support services and resources to those using cannabinoid products. The Realm is primarily lead by parent professionals whose children have benefitted from this therapy. The Realm of Caring currently serves nearly 28,000 members. For more information about the Realm of Caring’s programs and services, visit www.theroc.us.
For more information, photos or interview Chris Husong [email protected]


TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
Amazon in Talks to Invest $10 Billion in OpenAI as AI Firm Eyes $1 Trillion IPO Valuation
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
Treasury Wine Estates Shares Plunge on Earnings Warning Amid U.S. and China Weakness
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies
Republicans Raise National Security Concerns Over Intel’s Testing of China-Linked Chipmaking Tools
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy 



